Christopher R. Fenimore insider trades
Open-market stock purchases and sales by Christopher R. Fenimore, EVP Finance CFO at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 12, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 18, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold (not open market) | $3.7M |
| Aug 18, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 8, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold (not open market) | $707K |
| Dec 5, 2025 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 5, 2025 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- REGN Regeneron Pharmaceuticals, Inc: 78 sales, last Aug 18, 2026
Get free alerts when Christopher R. Fenimore files a new trade →